Efficacy News and Research

RSS
Repurposing or improving drugs for spinocerebellar ataxia type 5

Repurposing or improving drugs for spinocerebellar ataxia type 5

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Study highlights the interconnectedness of autoimmunity and cancer

Study highlights the interconnectedness of autoimmunity and cancer

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

UIC scientists find new way to better target cellular proteins

UIC scientists find new way to better target cellular proteins

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Do nuts help with type 2 diabetes?

Do nuts help with type 2 diabetes?

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Two cardiovascular drugs may help improve outcomes for patients who experienced small vessel stroke

Two cardiovascular drugs may help improve outcomes for patients who experienced small vessel stroke

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

The immunogenicity of two leading malaria vaccine candidates delivered as mRNA-LNP vaccines

The immunogenicity of two leading malaria vaccine candidates delivered as mRNA-LNP vaccines

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

UQ-led research effort secures almost $8 million to develop an mRNA Strep A vaccine

UQ-led research effort secures almost $8 million to develop an mRNA Strep A vaccine

Pegylated interferon lambda shows good efficacy against COVID-19

Pegylated interferon lambda shows good efficacy against COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.